iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 111.18
+4.58 (4.30%)
Apr 16, 2026, 3:00 PM CST
iRay Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,251 | 1,713 | 1,807 | 1,504 | 1,126 |
Other Revenue | - | 118.51 | 57.07 | 44.93 | 61.34 |
| 2,251 | 1,831 | 1,864 | 1,549 | 1,187 | |
Revenue Growth (YoY) | 22.90% | -1.74% | 20.31% | 30.47% | 51.43% |
Cost of Revenue | 1,095 | 915.26 | 804.52 | 661.77 | 531.35 |
Gross Profit | 1,156 | 916.13 | 1,059 | 887.34 | 656 |
Selling, General & Admin | 213.67 | 212.07 | 181.77 | 176.83 | 114.68 |
Research & Development | 339.7 | 304.65 | 260.95 | 238.62 | 145.66 |
Other Operating Expenses | -67.93 | -82.69 | -28.62 | -4.42 | 5 |
Operating Expenses | 485.44 | 442.8 | 418.04 | 396.94 | 274.78 |
Operating Income | 670.48 | 473.33 | 641.24 | 490.4 | 381.22 |
Interest Expense | - | -26.81 | -25.01 | -12.36 | -2.27 |
Interest & Investment Income | 34.54 | 67.18 | 61.35 | 52.78 | 60.29 |
Currency Exchange Gain (Loss) | - | 4.28 | 9.51 | 40.42 | -8.17 |
Other Non Operating Income (Expenses) | -8.77 | -4.25 | -2.18 | 0.95 | -0.52 |
EBT Excluding Unusual Items | 696.25 | 513.73 | 684.91 | 572.21 | 430.56 |
Gain (Loss) on Sale of Investments | -11.43 | -49.03 | -76.05 | 51.34 | 81.16 |
Gain (Loss) on Sale of Assets | 0.83 | - | - | 0.08 | -0.03 |
Asset Writedown | - | -0.05 | -0.04 | -0.05 | - |
Other Unusual Items | - | 42.63 | 76.17 | 85.11 | 48.24 |
Pretax Income | 685.65 | 507.28 | 684.99 | 708.69 | 559.93 |
Income Tax Expense | 53.47 | 56.87 | 80.21 | 69.98 | 75.36 |
Earnings From Continuing Operations | 632.19 | 450.4 | 604.77 | 638.71 | 484.57 |
Minority Interest in Earnings | 17.82 | 14.77 | 2.72 | 2.59 | -0.53 |
Net Income | 650.01 | 465.18 | 607.5 | 641.3 | 484.04 |
Net Income to Common | 650.01 | 465.18 | 607.5 | 641.3 | 484.04 |
Net Income Growth | 39.73% | -23.43% | -5.27% | 32.49% | 117.79% |
Shares Outstanding (Basic) | 203 | 200 | 200 | 199 | 199 |
Shares Outstanding (Diluted) | 210 | 208 | 203 | 200 | 199 |
Shares Change (YoY) | 1.10% | 2.26% | 1.98% | 0.19% | 23.10% |
EPS (Basic) | 3.20 | 2.33 | 3.04 | 3.22 | 2.43 |
EPS (Diluted) | 3.09 | 2.24 | 2.99 | 3.21 | 2.43 |
EPS Growth | 38.21% | -25.12% | -7.11% | 32.23% | 76.93% |
Free Cash Flow | -384.47 | -1,081 | -1,513 | -400.7 | 56.31 |
Free Cash Flow Per Share | -1.83 | -5.20 | -7.44 | -2.01 | 0.28 |
Dividend Per Share | - | 0.714 | 1.020 | 1.057 | 0.802 |
Dividend Growth | - | -30.00% | -3.45% | 31.83% | 120.01% |
Gross Margin | 51.36% | 50.02% | 56.83% | 57.28% | 55.25% |
Operating Margin | 29.79% | 25.85% | 34.41% | 31.66% | 32.11% |
Profit Margin | 28.88% | 25.40% | 32.59% | 41.40% | 40.77% |
Free Cash Flow Margin | -17.08% | -59.02% | -81.19% | -25.87% | 4.74% |
EBITDA | 812.91 | 521.07 | 672.08 | 519.11 | 405.36 |
EBITDA Margin | 36.12% | 28.45% | 36.06% | 33.51% | 34.14% |
D&A For EBITDA | 142.44 | 47.75 | 30.85 | 28.7 | 24.13 |
EBIT | 670.48 | 473.33 | 641.24 | 490.4 | 381.22 |
EBIT Margin | 29.79% | 25.85% | 34.41% | 31.66% | 32.11% |
Effective Tax Rate | 7.80% | 11.21% | 11.71% | 9.88% | 13.46% |
Revenue as Reported | - | 1,831 | 1,864 | 1,549 | 1,187 |
Advertising Expenses | - | 1.03 | 1.42 | 1.74 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.